Free MRSA Webinar

The first individual country speakers have now been announced:

• Denmark
  Anders Rhod Larsen
  Head of National Reference Laboratory, Statens Serum Institut, Copenhagen
  
  
• Germany
  Guido Werner
  Medical microbiologist, Department of Infectious Diseases, Robert Koch Institute, Wernigerode
  
  
• Netherlands
  Leo Schouls
  Molecular microbiologist, Infectious Diseases Research, Diagnostics and laboratory Surveillance (IDS), Centre for Infectious Disease Control Netherlands (CIb), National Institute for Public Health and the Environment
  
  
• Poland
  Joanna Empel
  National Reference Centre for Susceptibility Testing (KORLD), Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw
  
  
• Switzerland
  Domnique Blanc
  Lausanne University Hospital, Lausanne
  
  
• Switzerland
  Andreas Kronenberg
  Institute for Infectious Diseases, University of Bern
  
  
• Belgium
  Boudewijn Catry
  Head of Unit Healthcare-associated infection and antimicrobial resistance, Sciensano, Brussels
  
  
• France
  Aurélie Chabaud
  SPARES mission, Microbiologist at Limoges University Hospital, Limoges
  
  
• France
  Francois Vandenesch
  Director National Reference center for Staphylococci, Lyon
  
  

We invite you to take part in this conference, sponsored by the MRSA Working Group of the International Society of Antimicrobial Chemotherapy (ISAC), to review national and regional surveillance programs for Methicillin-Resistant Staphylococcus aureus (MRSA).

The first meeting will include brief presentations from laboratories in several countries that undertake MRSA surveillance. This will be followed by a period of moderated discussion to assess best practices. The goals are to understand the variety of approaches to surveillance worldwide and to develop principles that may underlie future harmonization of surveillance methods.

The conference is open to all and is free of charge.

Participants will be able to download a certificate of attendance during the webinar.